Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220763807> ?p ?o ?g. }
- W4220763807 endingPage "564" @default.
- W4220763807 startingPage "552" @default.
- W4220763807 abstract "Abstract Patients with hematological malignancies are at increased risk of severe COVID-19 outcomes due to compromised immune responses, but the insights of these studies have been compromised due to intrinsic limitations in study design. Here we present the PROSECO prospective observational study ( NCT04858568 ) on 457 patients with lymphoma that received two or three COVID-19 vaccine doses. We show undetectable humoral responses following two vaccine doses in 52% of patients undergoing active anticancer treatment. Moreover, 60% of patients on anti-CD20 therapy had undetectable antibodies following full vaccination within 12 months of receiving their anticancer therapy. However, 70% of individuals with indolent B-cell lymphoma displayed improved antibody responses following booster vaccination. Notably, 63% of all patients displayed antigen-specific T-cell responses, which increased after a third dose irrespective of their cancer treatment status. Our results emphasize the urgency of careful monitoring of COVID-19-specific immune responses to guide vaccination schemes in these vulnerable populations." @default.
- W4220763807 created "2022-04-03" @default.
- W4220763807 creator A5000986572 @default.
- W4220763807 creator A5003621086 @default.
- W4220763807 creator A5005070167 @default.
- W4220763807 creator A5007119947 @default.
- W4220763807 creator A5009757687 @default.
- W4220763807 creator A5011324204 @default.
- W4220763807 creator A5012355628 @default.
- W4220763807 creator A5012743329 @default.
- W4220763807 creator A5015087698 @default.
- W4220763807 creator A5021965002 @default.
- W4220763807 creator A5022695692 @default.
- W4220763807 creator A5027645258 @default.
- W4220763807 creator A5028077862 @default.
- W4220763807 creator A5034349671 @default.
- W4220763807 creator A5036750602 @default.
- W4220763807 creator A5037616399 @default.
- W4220763807 creator A5049418454 @default.
- W4220763807 creator A5050460105 @default.
- W4220763807 creator A5056201991 @default.
- W4220763807 creator A5058541730 @default.
- W4220763807 creator A5061182152 @default.
- W4220763807 creator A5065695489 @default.
- W4220763807 creator A5069477380 @default.
- W4220763807 creator A5071891268 @default.
- W4220763807 creator A5072495610 @default.
- W4220763807 creator A5073495986 @default.
- W4220763807 creator A5073745658 @default.
- W4220763807 creator A5074570151 @default.
- W4220763807 creator A5082526059 @default.
- W4220763807 creator A5082666045 @default.
- W4220763807 creator A5086600642 @default.
- W4220763807 creator A5087896361 @default.
- W4220763807 creator A5091500770 @default.
- W4220763807 creator A5057327774 @default.
- W4220763807 date "2022-03-24" @default.
- W4220763807 modified "2023-10-17" @default.
- W4220763807 title "Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study" @default.
- W4220763807 cites W1990765152 @default.
- W4220763807 cites W2151660872 @default.
- W4220763807 cites W2761878534 @default.
- W4220763807 cites W2774420072 @default.
- W4220763807 cites W2904110283 @default.
- W4220763807 cites W3010441732 @default.
- W4220763807 cites W3010496793 @default.
- W4220763807 cites W3044482768 @default.
- W4220763807 cites W3046550871 @default.
- W4220763807 cites W3080086449 @default.
- W4220763807 cites W3080162924 @default.
- W4220763807 cites W3111255098 @default.
- W4220763807 cites W3156866359 @default.
- W4220763807 cites W3162400064 @default.
- W4220763807 cites W3163785571 @default.
- W4220763807 cites W3164547793 @default.
- W4220763807 cites W3165224470 @default.
- W4220763807 cites W3172958999 @default.
- W4220763807 cites W3173150656 @default.
- W4220763807 cites W3174178131 @default.
- W4220763807 cites W3174790825 @default.
- W4220763807 cites W3176215631 @default.
- W4220763807 cites W3184273969 @default.
- W4220763807 cites W3184620427 @default.
- W4220763807 cites W3189762432 @default.
- W4220763807 cites W3197504359 @default.
- W4220763807 cites W3198468926 @default.
- W4220763807 cites W3200136047 @default.
- W4220763807 cites W3207546559 @default.
- W4220763807 cites W4200033584 @default.
- W4220763807 cites W4225569559 @default.
- W4220763807 cites W4225711802 @default.
- W4220763807 doi "https://doi.org/10.1038/s43018-022-00364-3" @default.
- W4220763807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35332334" @default.
- W4220763807 hasPublicationYear "2022" @default.
- W4220763807 type Work @default.
- W4220763807 citedByCount "43" @default.
- W4220763807 countsByYear W42207638072022 @default.
- W4220763807 countsByYear W42207638072023 @default.
- W4220763807 crossrefType "journal-article" @default.
- W4220763807 hasAuthorship W4220763807A5000986572 @default.
- W4220763807 hasAuthorship W4220763807A5003621086 @default.
- W4220763807 hasAuthorship W4220763807A5005070167 @default.
- W4220763807 hasAuthorship W4220763807A5007119947 @default.
- W4220763807 hasAuthorship W4220763807A5009757687 @default.
- W4220763807 hasAuthorship W4220763807A5011324204 @default.
- W4220763807 hasAuthorship W4220763807A5012355628 @default.
- W4220763807 hasAuthorship W4220763807A5012743329 @default.
- W4220763807 hasAuthorship W4220763807A5015087698 @default.
- W4220763807 hasAuthorship W4220763807A5021965002 @default.
- W4220763807 hasAuthorship W4220763807A5022695692 @default.
- W4220763807 hasAuthorship W4220763807A5027645258 @default.
- W4220763807 hasAuthorship W4220763807A5028077862 @default.
- W4220763807 hasAuthorship W4220763807A5034349671 @default.
- W4220763807 hasAuthorship W4220763807A5036750602 @default.
- W4220763807 hasAuthorship W4220763807A5037616399 @default.
- W4220763807 hasAuthorship W4220763807A5049418454 @default.
- W4220763807 hasAuthorship W4220763807A5050460105 @default.
- W4220763807 hasAuthorship W4220763807A5056201991 @default.